Alamar Biosciences Inc.
ALMR | NASDAQ
$29.23
-$1.37 (-4.48%)
Nov 2, 2026, 10:35 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Revenue | 74.21M |
Cost of Revenue | 32.51M |
Gross Profit | 41.71M |
Operating Income | -31.33M |
Interest Income | 2.16M |
Pretax Income | -29.15M |
Net Income | -29.82M |
Selling & General & Admin | 35.57M |
Research & Development | 37.47M |
Other Expenses | n/a |
Operating Expenses | 73.04M |
Interest Expense | 401K |
Selling & Marketing Expenses | n/a |
Cost & Expenses | 105.55M |
Income Tax Expense | 665K |
Shares Outstanding (Basic) | 66.52M |
Shares Outstanding (Diluted) | 66.52M |
EPS (Basic) | -0.45 |
EPS (Diluted) | -0.45 |
EBITDA | -24.89M |
EBIT | -28.75M |
Depreciation & Amortization | 3.86M |
Add to Watchlist
Select watchlists to add or remove ALMR